A new breast cancer drug, trialled in Cardiff, is now available for patients to use. Kadcyla can add up to six months on to the lives of some sufferers. It can also reduce some of the side-effects associated with standard chemotherapy.
Professor Peter Barrett-Lee is the Medical director at Velindre Cancer Centre. A new drug Kadcyla is available for patients to use today. At the moment it can only be used to prolong the life of suffers in the later stages of breast-cancer.
But Professor Peter Barrett-Lee says in the future, the drug could be further developed 'to cure breast cancer.'